Mirum Pharmaceuticals Inc (MIRM)
Cost of Revenue
$113.10M
TTM · Period ending: · USD
MIRM Cost of Revenue
Latest reported$113.10Mperiod ending
Latest reported$113.10Mperiod ending
MIRM TTM Cost of Revenue ($0.00 → $113.10M)
TTM cost of revenue
High-resolution chart · PNG
MIRM cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 113,102,000 | |
| 106,175,000 | |
| 100,314,000 | |
| 94,756,000 | |
| 90,025,000 | |
| 86,831,000 | |
| 81,643,000 | |
| 83,883,000 | |
| 73,305,000 | |
| 59,890,000 | |
| 47,039,000 | |
| 26,513,000 | |
| 19,217,000 | |
| 14,929,000 | |
| 12,374,000 | |
| 9,783,000 | |
| 6,851,000 | |
| 4,327,000 | |
| 1,903,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |